SCLC, as intractable cancer, has “cool” tumor features, is characterized by low immunogenicity, less CD8+ T cell infiltration and inhibitory tumor microenvironment, therefore, the inability of immunotherapy to reverse the anti‐tumor function of T cells.53 This evidence concerns the gene CD8A and neoplasm.